[
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock outperforms competitors despite losses on the day",
    "summary": "Boston Scientific Corp. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=826a9e814becde6500011455a59f2f7aec6a05452443c677342c3b8d9a483b1b",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734108000,
      "headline": "Boston Scientific Corp. stock outperforms competitors despite losses on the day",
      "id": 132067215,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=826a9e814becde6500011455a59f2f7aec6a05452443c677342c3b8d9a483b1b"
    }
  },
  {
    "ts": null,
    "headline": "Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?",
    "summary": "Based on the average brokerage recommendation (ABR), Boston Scientific (BSX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?",
    "url": "https://finnhub.io/api/news?id=78fd3d86dc5dce6ebb71f99f196ce16ef6e825e34c1dacaaafffeb78004456ae",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734100210,
      "headline": "Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?",
      "id": 131972491,
      "image": "https://media.zenfs.com/en/zacks.com/26a86d59f0e8f1e82a35a92ae5684cd9",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Based on the average brokerage recommendation (ABR), Boston Scientific (BSX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?",
      "url": "https://finnhub.io/api/news?id=78fd3d86dc5dce6ebb71f99f196ce16ef6e825e34c1dacaaafffeb78004456ae"
    }
  },
  {
    "ts": null,
    "headline": "Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?",
    "summary": "Edward Lifesciences' robust potential in Structural heart and long-term strategy instill optimism.",
    "url": "https://finnhub.io/api/news?id=58b8a43ef881a83991bdeca7ccf057cec47294c352491e2debc6423948c34ecd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734099240,
      "headline": "Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?",
      "id": 131967848,
      "image": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Edward Lifesciences' robust potential in Structural heart and long-term strategy instill optimism.",
      "url": "https://finnhub.io/api/news?id=58b8a43ef881a83991bdeca7ccf057cec47294c352491e2debc6423948c34ecd"
    }
  }
]